‌

US Patent 11071725 Activating pyruvate kinase R

Patent 11071725 was granted and assigned to FORMA Therapeutics on July, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

FORMA Therapeutics

Current Assignee

FORMA Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

July 27, 2021

Patent Application Number

15929436

Date Filed

May 1, 2020

Patent Citations

US Patent 10100043 Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation

US Patent 10208052 Compositions for activating pyruvate kinase

US Patent 10266551 Compounds and uses thereof for the modulation of hemoglobin

US Patent 10315991 Compounds and uses thereof for the modulation of hemoglobin

US Patent 10377741 Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation

US Patent 10435393 Compounds and uses thereof for the modulation of hemoglobin

US Patent 10450269 Compounds and uses thereof for the modulation of hemoglobin

US Patent 10472371 Compositions for activating pyruvate kinase

...

Patent Primary Examiner

Zinna Northington Davis

Patent abstract

This disclosure provides compounds and compositions for activating pyruvate kinase R (PKR) and related methods of manufacturing and using these compounds and compositions.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11071725 Activating pyruvate kinase R

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.